The Autism Treatment Network: Bringing Best Practices to All Children With Autism.

The Autism Treatment Network and Autism Intervention Research Network on Physical Health were established in 2008 with goals of improving understanding of the medical aspects of autism spectrum disorders. Over the past decade, the combined network has conducted >2 dozen clinical studies, established clinical pathways for best practice, developed tool kits for professionals and families to support better care, and disseminated these works through numerous presentations at scientific meetings and publications in medical journals. As the joint network enters its second decade continuing this work, it is undergoing a transformation to increase these activities and accelerate their incorporation into clinical care at the primary care and specialty care levels. In this article, we describe the past accomplishments and present activities. We also outline planned undertakings such as the establishment of the Autism Learning Health Network, the increasing role of family members as co-producers of the work of the network, the growth of clinical trials activities with funding from foundations and industry, and expansion of work with primary care practices and autism specialty centers. We also discuss the challenges of supporting network activities and potential solutions to sustain the network.

Performance-enhancing technologies for steers grazing tall fescue pastures with varying levels of toxicity1.

The objective of this study was to evaluate a combination of best management practices strategy for steer calves grazing tall fescue pastures with a range of toxicity. The experiment was conducted over 2 grazing seasons (fall 2015 for 91 d and spring 2016 for 84 d). Steers (n = 80 within season, body weight [BW] = 197.0 ± 15.43 kg [fall] and 116.9 ± 4.88 [spring]) were stocked at 2.45 and 4.1 calves/ha in fall and spring, respectively, to 16 pastures with varying levels of toxicity based on interim ergovaline (EV) concentration within season. Pastures were assigned to either mineral (MIN, n = 8) only management (MGMT) or a cumulative MGMT (CM, n = 8). The CM treatment included an implant containing 40-mg trenbolone acetate, 8-mg estradiol, and 29-mg tylosin tartrate (Component TE-G with Tylan, Elanco Animal Health, Greenfield, IN), 150 mg/calf daily monensin (Elanco Animal Health), and 1% BW of a 50:50 corn gluten feed:soybean hull supplement (as-is basis). Data were analyzed within season using pasture as the experimental unit. For fall and spring, the EV concentration was 1,476 ± 883.2 and 1,173 ± 620.6 ppb, respectively, and ranged from 90 to 2,180 ppb. During the fall, forage allowance did not differ (P = 0.76) between CM and MIN. In the spring, however, forage allowance only differed for the month of June (P ≤ 0.05, 2.55 vs. 3.22 ± 0.177 kg DM/kg BW, for MIN and CM, respectively). In the fall, average daily gain (ADG) responded to the simple effects of EV (P = 0.01) and MGMT (P < 0.001), and ADG for MIN steers was explained by ADG = 0.41 - 0.000064 × EV, whereas ADG for CM was explained by ADG = 1.05 - 0.000064 × EV. In the spring, there was an EV × MGMT interaction (P = 0.03) for ADG. For MIN, ADG = 0.80 - 0.000278 × EV, whereas for CM, ADG = 0.94 + 0.000001835 × EV. In spring, the ADG response to CM relative to MIN increased as EV increased. The CM strategy resulted in lower blood urea nitrogen than MIN in fall and spring (P < 0.01), but prolactin and serum Cu were not affected by MGMT in either season. In conclusion, performance was improved within the fescue belt by implementing feeding strategies using implants, ionophores, and supplementation, but a detailed economic analysis is warranted. Further research is needed to evaluate CM programs under varied stocking rates and in combination with dilution of endophyte-infected fescue pastures with nontoxic grasses or legumes.